|
Premedication |
· Slow onset (30 mins) · Long duration (3-7 hours) · Variable duration (CYP2D6 polymorphism) · No amnesia |
|
General anaesthesia |
· Partial agonist -> ceiling effect, insufficient as sole agent · Prolonged hypotension · Delayed emergence |
|
Systemic analgesia |
· Sedation unwanted · Rebound agitation and hypertension with prolonged use o Requires weaning |
|
Neuraxial analgesia |
· Prolonged blockade -> inability to monitor motor function |
|
Reflex suppressant |
· Prolonged effect may be unwanted o Laryngoscopy o Surgery · Unable to titrate – bolus cf. infusion |
|
Myocardial ischaemia |
· Hypotension impairs myocardial oxygen supply |
|
Opioid withdrawal |
· Does not prevent psychological craving |
|
Essential hypertension |
· α2 adrenoceptor upregulation – not for prolonged use |
Feedback welcome at ketaminenightmares@gmail.com